2019 Winter Conference Coverage
All eyes are on this season’s new developments in ILD management and diagnosis.
Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
The IPF Cell Atlas
Launched: November 22, 2019
Senescence, Senolytics, and IPF
Launched: November 13, 2019
The PRECISIONS Study
Launched: November 13, 2019
Genomics and Transcriptomics in PF
Launched: November 13, 2019
Recent Findings from PF Registries
Launched: November 13, 2019
Recent Developments in IPF Diagnosis
Launched: November 13, 2019
Evaluating Pulmonary Rehab Added on to Antifibrotic Therapy
Launched: November 13, 2019
New Developments in Clinical Trials of Pulmonary Fibrosis
Launched: November 13, 2019
Antifibrotic Therapy in Patients w/Autoimmune-Associated ILD
Launched: November 13, 2019
Evaluating Gene Expression of Alveolar Macrophages and SAECs
Launched: November 13, 2019
Expanding the Use of Antifibrotic Therapy in Patients with PF
Launched: November 22, 2019
Considerations for the Management of Autoimmune-Related ILD and Chronic Hypersensitivity-Related ILD
Launched: November 22, 2019